Synthesis of Metabolite of Resveratrol by Beauveria bassiana: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Vivi Li and Version 1 by Dongyun Shin.

Resveratrol is a well-known dietary polyphenol because it has a variety of beneficial biological activities. The fungus Beauveria bassiana is one of the most frequently used microorganisms for the biotransformation of polyphenols. Recently, resvebassianol A (2), a glycosylated metabolite of resveratrol by B. bassiana, was isolated and structurally elucidated. It was demonstrated to exhibit antioxidant, regenerative, and anti-inflammatory activities with no cytotoxicity.

  • resveratrol
  • resvebassianol A
  • Beauveria bassiana
  • metabolites
  • glycoslyation

1. Introduction

Resveratrol (1, trans-3,5,4-trihydroxystilbene) is an important dietary polyphenol and naturally occurring phytoalexin found in grapes, red wine, berries, peanuts, olive oil, etc. [1,2,3][1][2][3]. It is produced by plants in response to environmental stress and fungal attack through the induction of resveratrol synthetase [4,5][4][5]. Resveratrol was first isolated from the roots of the white hellebore lily (Veratrum grandiflorum O. Loes) in 1940 [6]. Most of the biological activities of resveratrol have been shown by its trans stilbene isomer, while the cis stilbene isomer also occurs naturally [7]. Resveratrol exerts numerous biological activities such as antioxidant, anti-infective, anti-inflammatory, anti-ischemic, cardioprotective, neuroprotective, anti-aging, anti-viral, anti-obesity, and anti-cancer effects [8,9,10,11,12,13,14,15,16,17,18][8][9][10][11][12][13][14][15][16][17][18]. Recently, it was revealed that its ability to activate various deacetylase enzymes (sirtuins) could be responsible for the various biological properties and delay aging [19,20][19][20].
Despite their pharmacological activities, various in vivo studies have shown that the potential of polyphenols is impaired by their insolubility in water, ultraviolet light instability, poor intestinal absorption, short half-life, rapid clearance, low bioavailability, and rapid metabolism [21,22][21][22]. The introduction of a glycosyl moiety on polyphenols not only helps to enhance the solubility of substrates but also reduces their toxicity, which ultimately increases the activity of biosynthetic intermediates [23]. Moreover, the sugar moiety of polyphenol glycosides might play a major role in their absorption, resulting in an acceptable concentration in the circulatory streams [24]. Polyphenols are subjected to enzymatic oxidation by polyphenol oxidases in plants, during food processing, and also after human consumption, which can be protected by glycosylation [25]. The incorporation of sugar moieties into different types of pharmacophores, natural products, or prodrugs has been proven to improve anti-cancer activities [26].
Several glycosyl derivatives of resveratrol have been recognized in the roots of Poligonum cuspidatum such as piceid (3-O-β-D-glucosyl resveratrol), resveratroloside (4′-O-β-D-glucosylresveratrol), and 4′-O-β-D-glucosyl piceatannol [27]. Piceid has been shown to exhibit a broad range of biological activities [28].
The fungus Beauveria bassiana is the most frequently used biocatalyst and has been used to transform more than 300 bioactive compounds [29,30][29][30]. For instance, B. bassiana ATCC 7159 has been used for the biotransformation of curvularin and kaempferol, leading to the production of new metabolites resulting from 4-O-methyl glucosylation of the substrate, and was highly selective among different hydroxyl groups in the same molecule [30]. Recently, resvebassianol A (2) shown in Figure 1, was identified through biotransformation of resveratrol by B. bassiana and exhibited important pharmacological activities such as inhibition of inflammatory cytokine expression and cell rejuvenation. Moreover, compared with resveratrol, resvebassianol A proved to be less toxic and more stable [31].
Antioxidants 10 01509 g001 550
Figure 1. Chemical structures of resveratrol 1, resvebassianol A (2), and 3-O-β-(4‴-O-methylglucopyranosyl) resveratrol 3.
Several synthetic approaches for the formation of glycosidic bonds to phenolic OH in resveratrol have been reported. Direct coupling of resveratrol with a bromo-glucuronide donor was performed by Wang et al. for the synthesis of two glycoconjugates [32]. Coupling of resveratrol with glucuronyl bromide was performed using silver carbonate as an activator, in order to produce glucuronide-conjugated resveratrol in low yield, possibly due to the low solubility of resveratrol in organic solvents. Lucas et al. synthesized resveratrol 3-O-β-D-glucuronide by coupling a trichloroacetimidate glycosyl donor with protected resveratrol using TMSOTf and BF3.OEt2 as promoters [3]. Learmonth also synthesized two glucuronide conjugates of resveratrol, in which palladium-catalyzed Heck coupling of an iodo-O-β-D-glucuronate derivative and its corresponding styrene was adopted [33].
The structural uniqueness and natural resource scarcity of resvebassianol A for biological evaluation prompted us to develop an efficient synthetic method for the metabolite. In this study, we report the total synthesis of resvebassianol A (2), a metabolite of resveratrol by B. bassiana, and its regiomer, 3-O-β-(4‴-O-methylglucopyranosyl)resveratrol (3).

2. Results and Discussion

2.1. Retrosynthesis

Metabolite 2 and its regiomer 3 consist of a glycone attached to the aglycone moiety. The glycone moiety is 4-O-methyl glucopyranose, whereas the aglycone is a functional resveratrol featuring a stilbene core with a polyhydroxy group. Metabolite 2 is a structure in which 4-O-methylglucopyranose is attached to the 7-position hydroxyl group of resveratrol, whereas its regiomer 3 consists of a glycosyl moiety attached to the 3-position hydroxyl group of resveratrol. The synthesis of both metabolites involves a glycosylation reaction that introduces methylated glucose as the core reaction and the Heck reaction to form a stilbene skeleton [34].
Scheme 1 and Scheme 2 provide a retrosynthetic methodology for the synthesis of both metabolites 2 and 3. Stilbene moiety 2 and its regiomer 3 were constructed via palladium-catalyzed Heck coupling. The rate-limiting step of the glycosylation reaction was performed with selectively protected compound 6 and commercially available iodophenol 7. Compound 10 was obtained from the glycosylation of compound 6 and styrene 12, which was synthesized from readily available dihydroxy benzaldehyde 9.
Antioxidants 10 01509 sch001 550
Scheme 1. Retrosynthetic analysis of 4′-O-β- (4‴-O-methylglucopyranosyl)resveratrol 2.
Antioxidants 10 01509 sch002 550
Scheme 2. Retrosynthetic analysis of 3-O-β-(4‴-O-methylglucopyranosyl)resveratrol 3.

2.2. Chemistry

The reaction commenced with the preparation of the glycosyl donor, 4-O-methylglycopyranosyl bromide 6, as shown in Scheme 3, which involves eight steps from commercially available methyl-α-D-glucopyranoside 8. Regioselective protection of 4, 6-diol from the starting material was accomplished by the introduction of a 4,6-O-benzylidene group using benzaldehyde dimethyl acetal under acidic conditions, yielding protected compound 13. 2,3-Di-O-benzylation of 13 generated 14 using NaH and BnBr. Further regioselective opening of the benzylidene ring of intermediate 14 was conducted with the help of triethylsilane (TES) and trifluoroacetic acid (TFA) to obtain alcohol 15 [35]. Methylation of compound 15 with NaH and MeI in N, N-dimethylformamide yielded product 16, followed by hydrogenolysis to yield product 17. Acetylation of the hydroxy groups of 17 was performed using pyridine and acetic anhydride to yield 18, followed by the replacement of an anomeric methoxy group with an acetoxy group using boron trifluoride diethyl etherate to yield 19. Finally, grafting of the anomeric acetoxy group was performed to incorporate bromine using HBr (33% in acetic acid) to yield acylated glycosyl bromide 6 at 73% [36]. As the final compound, 4-O-methylglucopyranosyl bromide 6, has poor chemical stability, it is suitable to obtain a large amount of acetate compound 19 and synthesize 6 immediately when necessary.
Antioxidants 10 01509 sch003 550
Scheme 3. Synthesis of 4-O-methylglucopyransyl bromide 6.
3,5. Dihydroxystyrene 12 and 3,5 diacetoxyystyrene 5 were synthesized from commercially available 3,5-dihydroxy benzaldehyde 9 according to Scheme 4. Protection of the hydroxy group of 9 with TBDMS yielded 20, and the Wittig reaction yielded olefin 21 using methyltriphenylphosphonium bromide under basic conditions. The TBDMS group in intermediate 21 was removed using tetrabutylammonium fluoride (TBAF) to furnish dihydroxy styrene 12, and further acetylation of both hydroxy groups resulted in 12 at 70% yield.
Antioxidants 10 01509 sch004 550
Scheme 4. Synthesis of diacetoxystyrene 5 and dihydroxystyrene 12.
After obtaining 6 and 12, the next target was to synthesize substrates 4 and 10, which participate in the Heck reaction for the synthesis of the stilbene core.
We performed glycosylation of both iodophenol 7 and dihydroxystyrene 12 separately with 4-O-methylglycopyranosyl bromide 6 under different reaction conditions, as shown in Table 1 and Table 2. Using Ag2CO3 in acetonitrile produced low-yield glycoside products 4 and 10 up to 16% and 19%, respectively. We attempted to improve glycosylation using a phase transfer catalyst (TBAB) in a two-phase system (aqueous NaOH and K2CO3) in CHCl3. Unfortunately, the reaction yielded trace amounts. The reaction was incomplete, and the substrate was recovered for reuse. Bromide compound 6 can be decomposed into glycal by an alkaline water phase and phenoxide anion [37]. Therefore, excess use of water in the reaction lowers the yield of the compound. After utilizing several conditions (Table 1 and Table 2), the glycosylation reaction under the phase transfer catalyst BnNBu3Cl and K2CO3 as a base at room temperature yielded product 4 at 57% yield. The desired mono-glucosylated product 10 was obtained at 40% yield along with the undesired di-glucosylated product as a mixture, which was separated by column chromatography.
Table 1. Optimization of glycosylation reaction for synthesis of 4 a.
Antioxidants 10 01509 i001
Entry a Base Reagent Solvent Temp. (°C) Yield (%) d
1  
Table 2. Optimization of glycosylation reaction for synthesis of 10 a.
Antioxidants 10 01509 i002
Entry Base Reagent Solvent Temp. (°C) Yield (%) d
Ag2CO3 (1eq) CH3CN r.t 16
1   Ag2CO3 CH3CN r.t 19
2 b NaOH TBAB CHCl3:H2O (1:1) 45 14
3 
2 b NaOH TBAB CHCl3:H2O (1:1) 45 13 b K2CO3 TBAB CHCl3:H2O (1:1) 45
3 b17
K2CO3 TBAB CHCl3:H2O (1:1) 45 15 4 c K2CO3
4 c K2BnNBu3Cl CHCl3 r.t 57
a Reaction was carried out using 1 equiv of both starting materials 7 and 6. b Base (1.1 eq), TBAB (0.2 eq), c Base (2.5 eq), and BnNBu3Cl (0.1 eq). d Isolated yield.
CO
3
BnNBu
3
Cl
CHCl3 r.t 40
a Reaction was carried out using 1 equiv of both starting materials 6 and 12. b Base (1.1 eq), TBAB (0.2 eq), c Base (2.5 eq), and BnNBu3Cl (0.1 eq). d Isolated yield.
Aryl iodide 7 was the choice for palladium-catalyzed Heck coupling because of its greater reactivity over other aryl halides.
The palladium-catalyzed Heck reaction between glycosylated compounds 4 and 5 under (Pd(OAc)2, BnEt3N+Cl−, Bu3N) in warm acetonitrile produced 22 at 55% yield. Deprotection of the acetyl protecting groups of 22 under a methanolic solution of sodium methoxide resulted in metabolite 2 at 85% yield.
The hydroxy group of glycosylated product 10 was protected by acetylation to yield 23. Similar to Scheme 5, the protected product 23 undergoes a palladium-catalyzed Heck reaction with 4-iodophenyl acetate 11 to build styrene compound 24 at 80% yield. Finally, basic hydrolysis of the acetyl protecting groups under a methanolic solution of sodium methoxide afforded another metabolite, 3, at 84% yield (Scheme 6).
Antioxidants 10 01509 sch005 550
Scheme 5. Synthesis of 4′-O-β-(4‴-O-methylglucopyranosyl)resveratrol (2).
Antioxidants 10 01509 sch006 550
Scheme 6. Synthesis of 3-O-β-(4‴-O-methylglucopyranosyl)resveratrol (3).

3. Conclusions

In conclusion, an efficient total synthesis was performed for the preparation of resvebassianol A (2, a metabolite of resveratrol by Beauveria bassiana) and its regiomer (3) through glycosylation and a palladium-catalyzed Heck reaction. Resvebassianol A and regiomer 3 were synthesized in 11 and 12 linear steps, with overall yields of 7.5% and 6.3%, respectively. Incorporation of 4-O methyl glyosyl was performed through the glycosylation reaction and was optimized using a phase transfer catalyst with varying bases. This resulted in an elevated yield of up to 40% and 57%, respectively. Thus, this method can be helpful for the synthesis of metabolites that are difficult to obtain from plant sources and through microbial biotransformation. This strategy can also be used for the synthesis of other related metabolites.

References

  1. Jang, M.; Cai, L.; Udeani, G.O.; Slowing, K.V.; Thomas, C.F.; Beecher, C.W.W.; Fong, H.H.S.; Farnsworth, N.R.; Kinghorn, A.D.; Mehta, R.G.; et al. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes. Science 1997, 275, 218–220.
  2. Wang, Y.; Catana, F.; Yang, Y.; Roderick, R.; van Breemen, R.B. An LC-MS Method for Analyzing Total Resveratrol in Grape Juice, Cranberry Juice, and in Wine. J. Agric. Food Chem. 2002, 50, 431–435.
  3. Lucas, R.; Alcantara, D.; Morales, J.C. A concise synthesis of glucuronide metabolites of urolithin-B, resveratrol, and hydroxytyrosol. Carbohydr. Res. 2009, 344, 1340–1346.
  4. Fritzemeier, K.-H.; Kindl, H. Coordinate induction by UV light of stilbene synthase, phenylalanine ammonia-lyase and cinnamate 4-hydroxylase in leaves of vitaceae. Planta 1981, 151, 48–52.
  5. Schultz, T.P.; Boldin, W.D.; Fisher, T.H.; Nicholas, D.D.; Mcmurtrey, K.D.; Pobanz, K. Structure-fungicidal properties of some 3- and 4-hydroxylated stilbenes and bibenzyl analogues. Phytochemistry 1992, 31, 3801–3806.
  6. Takaoka, M. Of the phenolic substrate of hellebore (Veratrum grandiflorum Loes. fil.). J. Fac. Sci. Hokkaido Imper. Univ. 1940, 3, 1–16.
  7. Quideau, S.; Deffieux, D.; Pouységu, L. Resveratrol Still Has Something To Say about Aging! Angew. Chem. Int. Ed. 2012, 51, 6824–6826.
  8. Gülçin, I. Antioxidant properties of resveratrol: A structure—Activity insight. Innov. Food Sci. Emerg. Technol. 2010, 11, 210–218.
  9. Vestergaard, M.; Ingmer, H. Antibacterial and antifungal properties of resveratrol. Int. J. Antimicrob. Agents 2019, 53, 716–723.
  10. Lançon, A.; Frazzi, R.; Latruffe, N. Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases. Molecules 2016, 21, 304.
  11. Raval, A.P.; Lin, H.W.; Dave, K.R.; DeFazio, R.A.; Morte, D.; Kim, E.J.; Perez-Pinzon, M.A. Resveratrol and Ischemic Preconditioning in the Brain. Curr. Med. Chem. 2008, 15, 1545–1551.
  12. Cho, S.; Namkoong, K.; Shin, M.; Park, J.; Yang, E.; Ihm, J.; Thu, V.T.; Kim, H.K.; Han, J. Cardiovascular Protective Effects and Clinical Applications of Resveratrol. J. Med. Food 2017, 20, 323–334.
  13. Yang, X.; Xu, S.; Qian, Y.; Xiao, Q. Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury. Brain Behav. Immun. 2017, 64, 162–172.
  14. Moussa, C.; Hebron, M.; Huang, X.; Ahn, J.; Rissman, R.A.; Aisen, P.S.; Turner, R.S. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J. Neuroinflamm. 2017, 14, 1–10.
  15. Li, Y.-R.; Li, S.; Lin, C.-C. Effect of resveratrol and pterostilbene on aging and longevity. BioFactors 2018, 44, 69–82.
  16. Kapadia, G.J.; Azuine, M.A.; Tokuda, H.; Takasaki, M.; Mukainaka, T.; Konoshima, T.; Nishino, H. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res. 2002, 45, 499–505.
  17. Szkudelska, K.; Nogowski, L.; Szkudelski, T. Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J. Steroid Biochem. Mol. Biol. 2009, 113, 17–24.
  18. Dermani, F.K.; Saidijam, M.; Amini, R.; Mahdavinezhad, A.; Heydari, K.; Najafi, R. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells. J. Cell. Biochem. 2017, 118, 1547–1555.
  19. Porcu, M.; Chiarugi, A. The emerging therapeutic potential of sirtuin-interacting drugs: From cell death to lifespan extension. Trends Pharmacol. Sci. 2005, 26, 94–103.
  20. Shakibaei, M.; Harikumar, K.B.; Aggarwal, B.B. Resveratrol addiction: To die or not to die. Mol. Nutr. Food Res. 2009, 53, 115–128.
  21. Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006, 5, 493–506.
  22. Walle, T. Bioavailability of resveratrol. Ann. N. Y. Acad. Sci. 2011, 1215, 9–15.
  23. Shimoda, K.; Kubota, N.; Uesugi, D.; Hamada, H.; Tanigawa, M.; Hamada, H. Synthesis and pharmacological evaluation of glycosides of resveratrol, pterostilbene, and piceatannol. Ann. N. Y. Acad. Sci. 2015, 1348, 141–149.
  24. Biasutto, L.; Marotta, E.; Bradaschia, A.; Fallica, M.; Mattarei, A.; Garbisa, S.; Zoratti, M.; Paradisi, C. Soluble polyphenols: Synthesis and bioavailability of 3,4′,5-tri(α-d-glucose-3-O-succinyl) resveratrol. Bioorganic Med. Chem. Lett. 2009, 19, 6721–6724.
  25. Regev-Shoshani, G.; Shoseyov, O.; Bilkis, I.; Kerem, Z. Glycosylation of resveratrol protects it from enzymic oxidation. Biochem. J. 2003, 374, 157–163.
  26. Dembitsky, V.M. Astonishing diversity of natural surfactants: 5. Biologically active glycosides of aromatic metabolites. Lipids 2005, 40, 869–900.
  27. Torres, P.; Poveda, A.; Jimenez-Barbero, J.; Parra, J.L.; Comelles, F.; Ballesteros, A.O.; Plou, F.J. Enzymatic Synthesis of α-Glucosides of Resveratrol with Surfactant Activity. Adv. Synth. Catal. 2011, 353, 1077–1086.
  28. Cichewicz, R.H.; Kouzi, S.A. Biotransformation of Resveratrol to Piceid byBacillus cereus. J. Nat. Prod. 1998, 61, 1313–1314.
  29. Holland, H.L.; Morris, T.A.; Nava, P.J.; Zabic, M. A new paradigm for biohydroxylation by Beauveria bassiana ATCC 7159. Tetrahedron 1999, 55, 7441–7460.
  30. Zhan, J.; Gunatilaka, A.A.L. Selective 4′-O-methylglycosylation of the pentahydroxy-flavonoid quercetin byBeauveria bassianaATCC 7159. Biocatal. Biotransform. 2006, 24, 396–399.
  31. Ha, S.K.; Kang, M.C.; Lee, S.; Darlami, O.; Shin, D.; Choi, I.; Kim, K.H.; Kim, S.Y. Generation of Stilbene Glycoside with Promising Cell Rejuvenation Activity through Biotransformation by the Entomopathogenic Fungus Beauveria Bassiana. Biomedicines 2021, 9, 555.
  32. Wang, L.-X.; Heredia, A.; Song, H.; Zhang, Z.; Yu, B.; Davis, C.; Redfield, R. Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity. J. Pharm. Sci. 2004, 93, 2448–2457.
  33. Learmonth, D.A. A Concise Synthesis of the 3-O-β-D- and 4‘-O-β-D-Glucuronide Conjugates of trans-Resveratrol. Bioconjugate Chem. 2003, 14, 262–267.
  34. Botella, L.; Nájera, C. Synthesis of methylated resveratrol and analogues by Heck reactions in organic and aqueous solvents. Tetrahedron 2004, 60, 5563–5570.
  35. DeNinno, M.P.; Etienne, J.B.; Duplantier, K.C. A method for the selective reduction of carbohydrate 4,6-O-benzylidene acetals. Tetrahedron Lett. 1995, 36, 669–672.
  36. Montero, J.-L.; Winum, J.-Y.; Leydet, A.; Kamal, M.; Pavia, A.A.; Roque, J.-P. A convenient synthesis of peracetylated glycosyl halides using bismuth(III) halides as catalysts. Carbohydr. Res. 1997, 297, 175–180.
  37. Hongu, M.; Saito, K.; Tsujihara, K. Solid-Liquid Phase Transfer Catalyzed Novel Glycosylation Reaction of Phenols. Synth. Commun. 1999, 29, 2775–2781.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
Video Production Service
Feedback